Sarfaraz K. Niazi, PhD, shares his latest citizen's petition to the FDA, calling on the agency to waive clinical efficacy ...

A retrospective study from a single inflammatory bowel disease (IBD) center in Greece reported that from 2018 to 2022 the use ...

Number 5: Early market entry, manufacturing efficiency, and market share are critical to biosimilar development success, ...

Trastuzumab biosimilars saw significant market uptake in Japan after reimbursement incentives were implemented, but ...

To help bring down sky-high drug prices, President Donald Trump signed an executive order pushing for faster biosimilar ...

During Q1 2025, pharmaceutical companies accelerated biosimilar expansion through strategic acquisitions and partnerships in hopes of boosting patient access to lower-cost treatments in immunology and ...